Xerostomia: all 286 studies
Page 3 of 3. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial FloraCompletedNCT02677480Phase 1
- Deterioration of Resilient Denture Liners and Patient CharacteristicsCompletedNCT02587676
- Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin UseWithdrawnNCT02522936Phase 4
- Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck CancerCompletedNCT02474095Not applicable
- Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary HypofunctionCompletedNCT02446249Phase 1
- Effect of Childhood Radioiodine Therapy on Salivary FunctionCompletedNCT02375451
- Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic DiseasesCompletedNCT02317172Not applicable
- Neurological Effects of Acupuncture to Prevent Radiation-induced XerostomiaCompletedNCT02292368Not applicable
- Examining the Immunological Process of Autoimmune PatientsWithdrawnNCT02123147
- Endoscopic Treatment of Salivary Glands Affected by Sjögren's SyndromeStatus unknownNCT02112019Not applicable
- A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative CareCompletedNCT02067572Not applicable
- Observational Study of Dental Outcomes in Head and Neck Cancer PatientsCompletedNCT02057510
- A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA StudyCompletedNCT02049112Phase 4
- Exploratory Study in the Relief of Drug-induced Xerostomia Associated With HyposialiaCompletedNCT02005328Not applicable
- Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by MedicationWithdrawnNCT01960101Not applicable
- Efficacy Study of a Ginger and Cardamom Gelatin for Xerostomy in Terminally Ill PatientsCompletedNCT01915966Not applicable
- Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted ConditionsCompletedNCT01903122Early Phase 1
- Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed ConditionsCompletedNCT01903109Early Phase 1
- Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer PatientsCompletedNCT01885065Not applicable
- Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx CarcinomaCompletedNCT01874587Phase 3
- The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid CancerCompletedNCT01833650Not applicable
- Xylitol Disk Use in Adults With Dry MouthCompletedNCT01823445Not applicable
- Salivary Biomarkers for Sjögren's Syndrome DetectionCompletedNCT01807689
- A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine RegimensStatus unknownNCT01762514Phase 2
- Rebamipide AND Sjögren SyndromeStatus unknownNCT01759108Not applicable
- The Role of Xerostomia in Burning Mouth Syndrome: Case - Control StudyCompletedNCT01754740Not applicable
- Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During ChemotherapyCompletedNCT01737307Phase 2
- International Validation of the QLQ-OH17 for Oral HealthCompletedNCT01724333
- Effect of 0.1% Pilocarpine Mouthwash on XerostomiaCompletedNCT01627626Not applicable
- Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck CancerWithdrawnNCT01621048
- Treatment of Xerostomia by Herbal PreparationStatus unknownNCT01579877Not applicable
- Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective StudyWithdrawnNCT01532479
- An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal WetnessCompletedNCT01369589Phase 1/2
- Proof-of-concept (PoC) Study of APD515CompletedNCT01331746Phase 2
- Effects of Mucoprotective Product on XerostomiaCompletedNCT01316393Phase 4
- Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer SurvivorsCompletedNCT01272570
- Controlled Trial Of Acupuncture To Prevent Radiation-Induced XerostomiaActive, not recruitingNCT01266044Phase 3
- Comparative Analysis of BioXtra on XerostomiaCompletedNCT01195233Phase 2
- Treatment of Salivary Gland Hypofunction With Neuro- ElectrostimulationStatus unknownNCT01174329Phase 2/3
- Effect of Saliva Substitutes on Dental Hard Tissues in SituTerminatedNCT01165970Phase 2/3
- Acute and Longlasting Side Effects Caused by Radiotherapy in the Head and Neck AreaCompletedNCT00995319
- Salivary Bacteria and Oral Health Status in Children With ADHDCompletedNCT00966394
- Evaluation of Safety and Efficacy of Using Lipsus Device for Oral WettingStatus unknownNCT00945022Not applicable
- Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
- Effects of Hydroxychloroquine on Oral Complaints of Sjögren PatientsCompletedNCT00873496
- Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced XerostomiaStatus unknownNCT00862550Not applicable
- A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's SyndromeCompletedNCT00852839Phase 2
- Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry MouthCompletedNCT00750828
- Hyperbaric Oxygen for the Treatment of a Dry Mouth Which Occurred After RadiotherapyTerminatedNCT00682747Phase 2
- Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's SyndromeCompletedNCT00637793Phase 2
- Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck CancerTerminatedNCT00623129Not applicable
- Bioequivalency Study of 7.5 mg Pilocarpine Under Fed ConditionsCompletedNCT00618059Not applicable
- Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNCT00602524Not applicable
- Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNCT00601874Not applicable
- Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed ConditionsCompletedNCT00601211Not applicable
- Comparing Over-the-counter Dry Mouth Remedies After RadiationCompletedNCT00595933Phase 1
- Optical Sensor for Photodynamic Detection of Oral PathologyCompletedNCT00540774Not applicable
- Effects of Oral Care in the Neuroscience ICUCompletedNCT00518752Not applicable
- Evaluation of an Electro-stimulator for the Treatment of XerostomiaCompletedNCT00509808Phase 4
- Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced XerostomiaCompletedNCT00466388Phase 4
- Dental Safety Profile of High-Dose Radioiodine TherapyCompletedNCT00439478
- A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy TreatmentCompletedNCT00438048Phase 4
- Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?Status unknownNCT00431925
- Acupuncture for Prevention of Radiation-Induced XerostomiaCompletedNCT00430378Not applicable
- Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCompletedNCT00426543Phase 2
- Lipid Based Food Additives for Treating Patients With Dry MouthStatus unknownNCT00422370Not applicable
- Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer PatientsStatus unknownNCT00408759Phase 2
- Prevalence of Salivary Hypofunction in Patients With Globus PharyngeusCompletedNCT00381771
- Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer PatientsCompletedNCT00375180
- Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck CancerCompletedNCT00372320Phase 1
- OGT Spray in the Management of Xerostomia in the ElderlyCompletedNCT00350350
- Efficacy Study of Oxygenated Glycerol Triesters to Treat XerostomiaCompletedNCT00332618
- Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer PatientsCompletedNCT00168181Phase 3
- Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a ProcedureCompletedNCT00168116Phase 2
- Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck CarcinomasCompletedNCT00158691Phase 3
- Mouth Care Regimes During RadiotherapyCompletedNCT00138827Phase 4
- Randomized Amifostine For SCCHNCompletedNCT00095927Phase 2
- Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced XerostomiaStatus unknownNCT00081029Phase 3
- Study of Oral Bacteria in Patients With Dry MouthCompletedNCT00048685
- Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
- Natural History of Salivary Gland Dysfunction and Sjogren's SyndromeCompletedNCT00001852
- Pilot Study of Thalidomide to Treat Sjogren's SyndromeCompletedNCT00001599Phase 2
- DHEA Treatment for Sjogren's SyndromeCompletedNCT00001598Phase 2
- Structure and Functional Status of Parotid Glands Exposed to Therapeutic IrradiationCompletedNCT00001523
- Evaluation of Salivary Gland DysfunctionTerminatedNCT00001196
- Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167